Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 2Phase 2 1

Status

Completed 110Terminated 32Recruiting 25Active not recruiting 19Unknown 14Withdrawn 8Not yet recruiting 5Enrolling by invitation 2

Sponsor Class

OTHER 5

Study Type

Interventional 5Observational 3

Sponsor

Cancer Type

Other hematologic neoplasm 2Thoracic 1Plasma cell 1Myeloid 1

Conditions

Breast Neoplasms 430Neoplasms 284Carcinoma, Non-Small-Cell Lung 266Colorectal Neoplasms 228Lung Neoplasms 173Prostatic Neoplasms 171Carcinoma, Hepatocellular 156Stomach Neoplasms 129Leukemia, Myeloid, Acute 118Pancreatic Neoplasms 115Multiple Myeloma 105Recurrence 96Uterine Cervical Neoplasms 91Squamous Cell Carcinoma of Head and Neck 88Neoplasm Metastasis 87Rectal Neoplasms 85Ovarian Neoplasms 77Triple Negative Breast Neoplasms 75Small Cell Lung Carcinoma 72Head and Neck Neoplasms 68Brain Neoplasms 68Esophageal Neoplasms 64Glioblastoma 63Colonic Neoplasms 60Endometrial Neoplasms 58Melanoma 54Hematologic Neoplasms 53Motor Activity 50Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Nasopharyngeal Carcinoma 46

Interventions

pomalidomide 1daratumumab 1Quality of Life 1Genetic Testing 1Electrocardiography 1Dexamethasone 1Complementary Therapies 1Clinical Laboratory Techniques 1Bone Marrow Examination 1Azacitidine 111-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × Hematologic Diseases × Clear all
NCT07541326 2026-04-21

COMPLHEMATO

University Hospital, Limoges

Phase NA Not yet recruiting
85 enrolled
Other hematologic neoplasm

Hematologic Diseases, Hematologic Neoplasms

NCT07387354 2026-03-16

MDS

Thomas Jefferson University

Phase 1/2 Not yet recruiting
25 enrolled
Myeloid

Bone Marrow Diseases, Hematologic Diseases, Myelodysplastic Syndromes, Myeloproliferative Disorders

NCT07303881 2025-12-26

JACKPOT22

The First Affiliated Hospital of Guangzhou Medical University

Phase 2 Not yet recruiting
16 enrolled
Thoracic

Hematologic Diseases, Lung Neoplasms, Neoplasm Metastasis

NCT06843291 2025-02-24

UNIVERSAL GENETIC TESTING OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES (UGT)

Augusta University

Phase NA Not yet recruiting
100 enrolled
Other hematologic neoplasm

Hematologic Diseases, Hematologic Neoplasms

NCT05581875 2022-10-17

A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory

Hellenic Society of Hematology

Phase 1/2 Not yet recruiting
48 enrolled
Plasma cell

Blood Protein Disorders, Corneal Diseases, Hematologic Diseases, Multiple Myeloma, Neoplasms, Paraproteinemias, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡